BioSpace News Archive

Scientists Use Stem Cells to Develop Synthetic Mouse Embryo With Brain, Heartbeat

Using only stem cells from mice, scientists created a synthetic mouse embryo with a brain, a heartbeat and a yolk sac from which it receives nutrients.

August 26, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Zymergen Cuts 80 More Jobs, Parts Ways with Co-Founder

In an SEC filing, Zymergen revealed it was cutting 80 more jobs and parting with Zach Serber, its co-founder and chief scientific officer.

August 26, 2022
·
2 min read
·
Tristan Manalac
Deals

Pricing Debate Stalls Merck-Seagen Acquisition Deal

Merck’s bid to buy the cancer-focused Seagen has hit a roadblock after the two companies failed to agree on a price, according to a Bloomberg report.

August 26, 2022
·
2 min read
·
Tristan Manalac
Business

Finch Therapeutics Regains Rights to Two Takeda-Owned IBD Drugs

Following the termination of a multi-year collaboration with Takeda, Finch has regained the rights to two assets, FIN-524 and FIN-525, assessed for forms of inflammatory bowel disease.

August 26, 2022
·
2 min read
·
Alex Keown
Policy

Moderna Hits Pfizer and BioNTech with Patent Infringement Suits over COVID-19 Vaccine

Moderna announced it is filing lawsuits against Pfizer and BioNTech, alleging that the companies’ COVID-19 vaccine infringes patents covering its mRNA technology.

August 26, 2022
·
4 min read
·
Mark Terry
Policy

FDA Review: Incyte, Pfizer, Iovance and More

The FDA is keeping busy as summer winds down, with approvals, Orphan Drug Designations and other actions. Here’s what the agency has been up to this week.

August 26, 2022
·
5 min read
·
Mark Terry
Policy

U.S. and China Reportedly Near Deal to Avoid NASDAQ Delisting

The United States and China are reportedly close to an agreement that would allow the PCAOB to audit companies listed on the U.S. stock exchange, per the Wall Street Journal.

August 26, 2022
·
4 min read
·
Mark Terry
Drug Development

NEJM Publishes Data Touting Efficacy of TG Therapeutics’ MS Drug

TG Therapeutics announced the publication of Phase III trials of relapsing/remitting multiple sclerosis (RMS) drug candidate in the NEJM.

August 26, 2022
·
3 min read
·
Alex Keown
Business

Dr. Korch to Retire as NBACC Lab Director

Dr. George W. Korch announced his retirement at the end of September, 2022 as Director of the National Biodefense Analysis and Countermeasures Center and President of the Battelle National Biodefense Institute.

August 26, 2022
·
1 min read
Implantable Pelvic Floor Electrical Stimulation Devices Market Trends and Forecast up to 2030

Implantable pelvic floor electrical stimulation improves urinary incontinence due to an overactive bladder through the inhibitory spinal reflex mechanism

August 26, 2022
·
6 min read